Paul Simmons

This inventor holds 11 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Mesoblast International Sarl, Oaktree Fund Administration, LLC. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Simmons. Retrieved from https://idiyas.com/inventor/paul-simmons-axoel8zx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 12)

% Patents Active = 81.8

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 30(Granted Patents)

Location History:

Melbourne, AU (2019 - 2023)
Malbourne, AU (2023)

Company Filing History:

11 out of 43

Mesoblast International Sarl

patents

1 out of 2

Oaktree Fund Administration, LLC

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760276 - Expansion of hematopoietic stem cells (2026-10-13),

2. 12616722 - Treatment of immune disorders (2026-05-05),

3. 12257270 - Treatment of immune disorders (2025-03-25),

4. 12215352 - Cell culture method for mesenchymal stem cells (2025-02-04),

5. 11795435 - Potency assay (2023-10-24),

6. 11685899 - Cell culture method for mesenchymal stem cells (2023-06-27),

7. 11406669 - Treatment of immune disorders (2022-08-09),

8. 11312941 - Stem cell composition (2022-04-26),

9. 11242506 - Methods and apparatus for separating cells from microcarriers (2022-02-08),

10. 10624930 - Treatment of immune disorders (2020-04-21),

11. 10400218 - Stem cell composition (2019-09-03),

Title: Paul Simmons - Innovator in Stem Cell Research

Introduction

Paul Simmons is a prominent inventor based in Melbourne, Australia. He has made significant contributions to the field of stem cell research, holding a total of nine patents. His work focuses on innovative treatments for immune disorders and advancements in cell culture methods.

Latest Patents

One of his latest patents involves the treatment of immune disorders. This patent discloses stem cells that express high levels of Angiopoietin-1 (Ang1) and their use in inhibiting M1-type macrophage production, which is crucial for treating inflammatory diseases such as diabetes. Another notable patent is related to a cell culture method for mesenchymal stem cells. This patent describes a cell culture medium that promotes cell proliferation during serum-free cell culture, enhancing the efficiency of stem cell research.

Career Highlights

Throughout his career, Paul Simmons has worked with various organizations, including Mesoblast International Sarl and Mesoblast International Sárl. His innovative approaches and research have positioned him as a key figure in the field of regenerative medicine.

Collaborations

Some of his notable coworkers include Silviu Itescu and Colby Suire, who have collaborated with him on various projects in stem cell research.

Conclusion

Paul Simmons continues to be a driving force in the advancement of stem cell technology and treatments for immune disorders. His contributions are paving the way for future innovations in the medical field.

Profile summary based on public USPTO records.